Karl Folkers
23Patents
9h-index
26Co-inventors
75Inventor score
Filing activity: Jun 8, 1972 → Jun 6, 1995
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US4550109A | Lipoidal biopterin compounds | Human Necessities | 88 | Expired |
| US4824669A | Formulations of coenzyme Q.sub.10 for intravenous use | Human Necessities | 48 | Expired |
| US4481139A | Peptide antagonists of substance P | Emerging Cross-Sectional Technologies | 46 | Expired |
| US4935491A | Effective antagonists of the luteinizing hormone releasing hormone which release negligible histamine | Emerging Cross-Sectional Technologies | 24 | Expired |
| US5316765A | Use of coenzyme Q.sub.10 in combination with HMG-CoA reductase inhibitor therapies | Human Necessities | 23 | Expired |
| US6461593B1 | Therapy with coenzyme Q10 to reduce subgingival microorganisms in patients with periodontal disease | Human Necessities | 21 | Expired |
| US4504414A | Synthetic pyridyl-alanyl decapeptides having antiovulatory activity | Emerging Cross-Sectional Technologies | 19 | Expired |
| US4374828A | Biologically active thymones from the thymus | Emerging Cross-Sectional Technologies | 16 | Expired |
| US3953416A | Synthetic decapeptide having the activity of the luteinizing hormone releasing hormone and method for manufacturing the same | Emerging Cross-Sectional Technologies | 10 | Expired |
| US5470947A | CHRH antagonists with low histamine release | Emerging Cross-Sectional Technologies | 9 | Expired |
| US5082650A | Amelioration of reductions of coenzyme Q.sub.10 in cardiomyopathy patients receiving lovastatin | Human Necessities | 8 | Expired |
| US4642332A | Effective hormonal peptides: D-3-Pal.sup.6 -LHRH | Emerging Cross-Sectional Technologies | 7 | Expired |
| US4110321A | Synthetic tridecapeptide [Gln.sup.4 ]-neurotensin having hormonal activity | Human Necessities | 6 | Expired |
| US4721775A | Effective peptides related to the luteinizing hormone releasing hormone from L-amino acids | Emerging Cross-Sectional Technologies | 6 | Expired |
| US3974135A | Synthetic decapeptide having the activity of the luteinizing hormone releasing hormone and method for producing the same | Emerging Cross-Sectional Technologies | 6 | Expired |
| US4656247A | Effective hormonal peptides: D-3-QA1 6-LHRH | Emerging Cross-Sectional Technologies | 5 | Expired |
| US5480969A | Antagonists of LHRH | Human Necessities | 4 | Expired |
| US3944659A | Folliculotropin releasing hormone | Emerging Cross-Sectional Technologies | 2 | Expired |
| US4885167A | Restoration of impaired cardiac function of patients with diverse muscular dystrophies by therapy with coenzyme Q10 | Human Necessities | 2 | Expired |
| US5656727A | Antagonists of LHRH | Human Necessities | 1 | Expired |
| US5011858A | Therapy with coenzyme Q.sub.10 of patients having AIDS or other retroviral diseases | Human Necessities | 1 | Expired |
| US5763404A | Methods for using LHRH antagonists with low histamine release | Emerging Cross-Sectional Technologies | 0 | Expired |
| US3974187A | Synthetic analogs having the activity of naturally occurring forms of coenzyme Q | Chemistry; Metallurgy | 0 | Expired |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.